Executives from the five largest PBMs appeared at a Senate Finance Committee hearing to discuss their roles in pharmaceutical supply chain.
PBMs say Big Pharma is responsible for high drug prices, Alexa has new HIPAA-compliant skills, D-SNP look-alike plans may soon be at risk, and more industry news from the past week.
The FDA wants to hear your experiences with CBD, the telemedicine market is on the rise, and more healthcare and pharmacy news to know this week.
Welcome to the first edition of Amplicare’s weekly news roundup. Each week, we’ll share five news stories to keep you up-to-date on what’s happening in the healthcare and pharmaceutical industries. Look for us every Friday afternoon.
Open Enrollment is upon us! The Amplicare team analyzed the data out there and identified key changes to help you help your patients this Open Enrollment.
Created by the Centers for Medicare and Medicaid Services (CMS) in 2007, the Star Rating System is designed to incentivize Medicare Advantage and Part D plans to provide higher quality care. The rating also informs patients how well a plan performs, generating more transparency in the healthcare marketplace. High-performing plans enjoy rewards, like bonus payments and greater marketing opportunities. Plans that perform poorly, however, can experience serious penalties
On the surface, catastrophic healthcare coverage is a great thing. For the 44.5 million Medicare beneficiaries enrolled in the Part D program for self-administered prescription drugs, this coverage phase is designed to make out-of-pocket costs manageable, once drug spending crosses a certain threshold. Without it, many patients with chronic health conditions would not be able to access their medication.
But something has gone horribly wrong…
Studies predict a shortage of up to 121,300 physicians by 2030. This means access to primary care physicians is becoming more difficult. However, 9 in 10 Americans have a pharmacy within 5 miles of their home according to NACDS research. The pharmacist will become more and more important as an overall healthcare consultant.